TIM-3 as a molecular switch for tumor escape from innate immunity

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Mattei, Fabrizio ^a   Schiavoni, Giovanna ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874226565     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00418     Document Type: Note

References (9)

1. Anderson, A. C., and Anderson, D. E. (2006). TIM-3 in autoimmunity. Curr. Opin. Immunol. 18, 665-669.
2. Kokkola, R., Andersson, A., Mullins, G., Ostberg, T., Treutiger, C. J., Arnold, B., et al. (2005). RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1-9.
3. Mattei, F., Schiavoni, G., Spada, M., and Gabriele, L. (2009). Role of IRF-8 in the interface of melanoma tumor cell-immune system interaction. Eur. J. Immunol. 39, S621.
4. Mattei, F., Schiavoni, G., and Tough, D. E (2010). Regulation of immune cell homeostasis by type I interferons. Cytokine Growth Factor Rev. 21, 227-236.
5. Mattei, F., Sestili, P., Spadaro, F., Fragale, A., Sistigu, A., Lucarini, V., et al. (2012). IRF-8 controls melanoma progression by regulating the crosstalk between cancer and immune cells within the tumor microenvironment. Neoplasia 14, 1223-1235.
6. Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., et al. (2002). Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415, 536-541.
7. Nogueira-Machado, J. A., Volpe, C. M., Veloso, C. A., and Chaves, M. M. (2011). HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin. Ther. Targets 15, 1023-1035.
8. Pinto, A., Rega, A., Crother, T. R., and Sorrentino, R. (2012). Plasmacytoid dendritic cells and their therapeutic activity in cancer. Oncoimmunology 1, 726-734.
9. Pruefer, F. G., Lizarraga, F., Maldonado, V., and Melendez-Zajgla, J. (2008). Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J. Chemother. 20, 348-354